The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer (Q80414714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

10

Alex A Adjei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

James R Jett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Sumithra J Mandrekar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Aminah Jatoi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

William L McGinnis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Phillip J Stella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Richard L Deming

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yolanda I Garces

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Katie L Allen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

363-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22780

7 January 2021

Identifiers

DOI

10.1002/CNCR.22780

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542000%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference